Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been shown to halt disease progression in Crohn's disease and certain cancers, to reduce symptoms in multiple sclerosis and autism, and to improve numerous autoimmune and neurodegenerative conditions, including Parkinson's disease and amyotrophic lateral sclerosis (ALS).
Grounded in clinical and scientific research, this book describes the history of naltrexone, its potential therapeutic uses, its effects on the immune system, its pharmacological properties, and how the drug is administered. It also lists fillers and compounding pharmacies, doctors who prescribe LDN, and patient resources, and includes interviews with LDN patients and researchers....

Graves' Disease, a common form of hyperthyroidism characterized by a goiter and often a slight protrusion of the eyeballs, currently affects approximately 200 million people worldwide, three million in the United States alone. This work addresses both typical and special concerns of patients with Graves' Disease, discusses its association with related autoimmune disorders, and emphasizes the patient's role in the healing process. Included are chapters with basic information on the disease, the thyroid and its hormones, Graves' ophthalmopathy, dermopathy, and acropachy, the diagnosis of GD, autoantibodies and autoimmune diseases associated with it, genetic and nongenetic influences, allopathic treatments, alternative medicine, special considerations in pregnant women, children, and teens, hyperthyroidism associated with GD, anecdotes and testimony of patients, and resources for further information. A list of medical acronyms and a glossary of medical terms is included...